Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study
- 18 July 1998
- journal article
- clinical trial
- Published by Elsevier
- Vol. 352 (9123) , 185-190
- https://doi.org/10.1016/s0140-6736(98)06193-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Induction–maintenance antiretroviral therapyAIDS, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudineAIDS, 1998
- Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centresAIDS, 1997
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Quantification of HIV-1 viral load in lymphoid and blood cellsAIDS, 1997
- Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 InfectionScience, 1997
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Nucleoside Analogs: Similarities and DifferencesClinical Infectious Diseases, 1993
- Competition between zidovudine-sensitive and zidovudine-resistant strains of HIVAIDS, 1992